Clinical Trials Sponsored by Aktiia SA

Total 1122 results

LimFlow SA

Active, not recruiting

Percutaneous Deep Vein Arterialization Post-Market Study (PROMISE UK)

Critical Limb Ischemia

United Kingdom
Carmat SA

Suspended

European Clinical Evaluation of the Carmat Total Artificial Heart (ADVANCEHF)

Advanced Heart Failure

Netherlands, Kazakhstan
Abionic SA

Completed

Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2

COVID-19 | COVID-19 Pandemic

Italy
Remedee SA

Completed

Evaluation of the Effectiveness of the Remedee Solution in Fibromyalgia (Fibrepik)

Fibromyalgia

France
Sintetica SA

Completed

Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.

Cataract

Italy, Slovakia, Spain
Teoxane SA

Active, not recruiting

TEOSYAL RHA® 1 for Neck Lines, Perioral Lines and Smiling Lines

Skin Aging | Fine Lines of the Face and Neck

Spain
Cardiawave SA

Completed

A Prospective RegistrY of Cardiac Echographic Loops (ARYEL)

Calcified Aortic Valve

France
ObsEva SA

Completed

Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF (IMPLANT4)

Infertility

Belgium, Canada, Czechia, Denmark, Estonia, Germany, Hungary, Poland, Russian Federation, Spain
ObsEva SA

Completed

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids (PRIMROSE 1)

Uterine Fibroids | Heavy Menstrual Bleeding

United States
Aspivix SA

Completed

Usability, Safety and Efficacy of AspivixTM

IUD Insertion

Switzerland
Ixaltis SA

Completed

DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence

Urinary Incontinence

United States
Mabion SA

Completed

MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Serbia, Poland, Bosnia and Herzegovina, Georgia, Ukraine
Axalbion SA

Completed

AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects

Healthy

United Kingdom
Imcyse SA

Completed

Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes

Type 1 Diabetes Mellitus

United Kingdom, Belgium, Denmark, Germany, Lithuania, Sweden, France
Celergan SA

Completed

Efficacy and Tolerability of CELERGEN in Fibromyalgia

Fibromyalgia

Spain
Poxel SA

Completed

Pharmacokinetics and Metabolism of (14C)-Labelled PXL770

Healthy

United Kingdom
Poxel SA

Completed

Bioequivalence of Imeglimin Tablet Formulations

Bioequivalence

United Kingdom
Him SA

Completed

SMARTCARE Project: Deploying Integrated Health & Social Services for Independent Living by Older People (SmartCare)

Frail Elderly Syndrome | Congestive Heart Failure | Falls Prevention
Mindmaze SA

Terminated

Study Evaluating the MindMotionPRO for Early Post-stroke Upper-limb Rehabilitation (MOVE-Rehab)

Stroke | Motor Disorders

Germany, Italy, United Kingdom
ObsEva SA

Terminated

A Phase 2 Study of OBE001 Versus Placebo in the Delay of Preterm Birth (TERM)

Preterm Labor

Poland, United Kingdom, Spain, Switzerland, Belgium, Germany
Poxel SA

Completed

Safety, Tolerability and PK of Imeglimin in Japanese Volunteers

Type 2 Diabetes Mellitus

United Kingdom
Xigen SA

Completed

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation and Pain

Pain | Inflammation | Cataract

United States
Xigen SA

Completed

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation

Pain | Inflammation | Cataract

United States
Teoxane SA

Completed

TEOSYAL® PureSense Redensity [I] Injection Using MicronJet® Needle in the Treatment of Crow's Feet Wrinkles

Crow's Feet Wrinkles

Switzerland
Luzitin SA

Unknown

Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer

Head and Neck Cancer

Portugal
Creabilis SA

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis

Atopic Dermatitis

United Kingdom
PregLem SA

Unknown

A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids (PREMYA)

Uterine Fibroids

United Kingdom, Spain, Italy, France, Germany, Austria, Hungary, Poland, Portugal, Romania
PregLem SA

Completed

PGL2001 Proof of Concept Study in Symptomatic Endometriosis (AMBER)

Endometriosis

Hungary, Romania, Poland
Cytheris SA

Terminated

Study on Interleukin-7 (CYT107) in HIV Patients (Inspire 2)

HIV

United States, Canada
PregLem SA

Completed

PGL4001 Versus GnRH-agonist in Uterine Myomas (PEARLII)

Uterine Myomas

Spain, Germany, Austria, Israel, Poland, Italy, Belgium, France, Netherlands
Creabilis SA

Withdrawn

CT 327 in the "Atopy Patch Test" Model (CT327 AD01-09)

Atopic Dermatitis

Germany
Creabilis SA

Completed

CT 327 in the Treatment of Psoriasis Vulgaris

Psoriasis

Switzerland, United States, United Kingdom
Artiva Biotherapeutics, Inc.

Recruiting

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis

Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class III

United States
Artiva Biotherapeutics, Inc.

Not yet recruiting

A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors

Breast Cancer | Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

Korea, Republic of, United States
Astria Therapeutics, Inc.

Completed

A Study of STAR-0215 in Healthy Adult Participants

Hereditary Angioedema

United States
Aktion Bronchialkarzinom e.V.

Completed

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

Non-Small-Cell Lung Carcinoma

Germany
Astria Therapeutics, Inc.

Recruiting

A Study of STAR-0215 in Participants With Hereditary Angioedema

Hereditary Angioedema

United States, United Kingdom, Canada, Germany, Bulgaria, Czechia
Artiva Biotherapeutics, Inc.

Recruiting

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Non Hodgkin Lymphoma

United States
Astria Therapeutics, Inc.

Enrolling by invitation

A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema

Hereditary Angioedema

United States, Canada
Debiopharm International SA

Not yet recruiting

A Dose Finding Study of Debio 4228 in Participants With Locally Advanced/Metastatic Prostate Cancer

Prostate Cancer
Auregen Biotherapeutics, SA

Recruiting

Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201 (AUR-201)

Microtia

United States
Auregen Biotherapeutics, SA

Recruiting

Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (AUR-201)

Microtia

United States
Ichnos Sciences SA

Not yet recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

Australia
Medacta International SA

Recruiting

Monocer AOANJRR Registry-nested Study

Survival, Prosthesis

Australia
Rose Pharma SA

Recruiting

An Open, Non-comparative, Single-centre Post Marketing Clinical Followup (PMCF) Investigation to Evaluate Performance and Safety of the ALIAXIN Fillers Used as Intended

Esthetics

Italy
Biosensors Europe SA

Recruiting

ALPHA LONG Study- BioMatrix AlphaTM Stent Study in Patients With CAD

Coronary Artery Disease

United Kingdom
Debiopharm International SA

Recruiting

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Astrocytoma, Grade III | Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Spain, United States, Switzerland
Medacta International SA

Recruiting

Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty

Arthritis | Avascular Necrosis | Traumatic Arthritis

Austria
EP Solutions SA

Recruiting

Improving CRT Outcome With Non-Invasive Cardiac Mapping (ICONIC-M)

Heart Failure With Reduced Ejection Fraction

Sweden, Netherlands, Portugal, United Kingdom
Medesis Pharma SA

Recruiting

Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease (NanoLi®_AD)

Alzheimer's Disease

France

3

Subscribe